Ixazomib (active substance) - analogs
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: Instructions Ixazomib | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Ixazomib included in the composition |
Prices in pharmacies |
Ninlaro | 2417.8€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 60% Carfilzomib
- 49% Daratumumab
- 46% Palbociclib
- 38% Cabozantinib
- 36% Elotuzumab
- 34% Pomalidomide
- 33% Imatinib
- 32% Nilotinib
- 30% Lorlatinib
- 30% Pegvisomant
- 30% Talazoparib
- 30% Thyrotropin alfa
- 29% Panobinostat
- 28% Ibrutinib
- 25% Dasatinib
- 25% Bosutinib
- 25% Akalabrutinib
- 24% Vandetanib
- 23% Netupitant+Palonosetron [Palonosetron]
- 23% Abemaciclib
- 23% Isatuximab
- 22% Trametinib
- 22% Osimertinib
- 22% Sorafenib
- 22% Ceritinib
- 22% Ribociklib
- 22% Afatinib
- 21% Dutasteride
- 21% Ruxolitinib
- 21% Palonosetron
- 20% Letrozole
- 20% Pazopanib
- 20% Crizotinib
- 18% Anastrozole
- 18% Nintedanib
- 18% Dutasteride+Tamsulosin [Dutasteride and more 1Tamsulosin]
- 18% Nivolumab
- 18% Vinflunine
- 17% Cobimetinib
- 17% Vemurafenib
- 17% Lenalidomide
- 17% Nilutamide
- 17% Dabrafenib
- 16% Diindolylmethane
- 15% Gefitinib
- 15% Idarubicin
- 15% Bendamustine
- 14% Abiraterone
- 14% Regorafenib
- 14% Lenvatinib
Learn more about the selection of analogues
- The drug has «Ixazomib» 51 analog by action, the most similar - Carfilzomib .
- Medical online service has selected the best substitutes for Ixazomib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Ixazomib to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.